Scientific News
The findings show that statin-induced high blood sugar levels are associated with Clostridium bacteria and bile acids. The work also suggests that ursodiol may help reduce the adverse effects of…
Satish Chandran, President and Chief Executive Officer at Prodigy Biotech, Inc., details the company's program aimed at treating alcoholic liver disease, spotlighting Enterococcus faecalis as the primary antagonist.
Two weeks of dietary intervention are sufficient to influence host immunity, metabolism and gut microbiota composition.
The results of a recent study reveal that the severity of respiratory infections depends at least in part on a complex interplay between the gut microbiota and the immune system.
Aran Singanayagam, research group leader at Imperial College London (UK), examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases.
The results of a recent study shed light on the effects of aspirin use on the gut microbiota. The findings may also inform therapies for aspirin-mediated gastrointestinal damage.
The findings of a recent study shed light on the role of complement proteins in breast milk and provide a mechanism through which breastfeeding may provide protection from certain bacterial…
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…
The findings of a recent study suggest that antimicrobial-resistance mutations in commensal bacteria can make the microbiota surprisingly resilient to antibiotics.
The findings of a recent study suggest that the gut microbiota contributes to alterations in the levels of metabolites associated with ulcerative colitis.
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
The findings suggest that microbial metabolites can help to predict who is at increased risk of infection after liver transplant. The results may also help to inform microbiota-targeted therapies.
Socially transmissible microbes may influence human health and play a hidden role in social evolution.
Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.
By examining the gut-brain-microbiota axis in typical neurodevelopment, the findings could pave the way for identifying biomarkers for cognition and brain development.
The findings of a recent study shed light on why gut microbiota diversity protects against infection. The results may also inform the design of pathogen-resistant microbial communities.
The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.
The findings of a recent study suggest that L. reuteri eases social difficulties in autistic children.
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.
